pefloxacin has been researched along with Primary Peritonitis in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (50.00) | 18.7374 |
| 1990's | 9 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Iudin, SM; Lobuseva, AN | 1 |
| Bernheim, J; Korzets, Z; Maayan, MC | 1 |
| Andremont, A; Carbon, C; Massias, L; Montravers, P | 1 |
| Lee, EJ; Lye, WC; van der Straaten, J | 1 |
| Chua, CT; Kon, SP; Ngeow, NF; Tan, HW | 1 |
| Dombros, N; Nikolaidis, P; Oreopoulos, DG; Paton, TW; Tourkantonis, A; Walker, SE | 1 |
| Janknegt, R | 1 |
| Bremner, DA; Collins, J; Ellis-Pegler, R; Isaacs, R; Richardson, R; Rose, TF; Small, M | 1 |
| Collins, J; Ellis-Pegler, R; Rose, TF; Small, M | 1 |
| Cristina, T; Daniela, C; Mario, C; Romano, C | 1 |
| Bellido, F; Lucain, C; Pechére, JC; Regamey, P | 1 |
| Delisle, F; Lependoven, C; Michel, C; Mignon, F; Viron, B | 1 |
| Edlund, C; Lahnborg, G; Nord, CE | 1 |
| Benevent, D; Benzakour, M; Denis, F; Lagarde, C; Mounier, M | 1 |
| Auckenthaler, R; Marchou, B; Michéa-Hamzehpour, M; Pechère, JC | 1 |
| Auckenthaler, R; Michéa-Hamzehpour, M; Pechère, JC; Regamey, P | 1 |
| Benevent, D; Denis, F; Lagarde, C; Mounier, M | 1 |
| Dupon, M; Ragnaud, JM; Roche-Bezian, MC; Wone, C | 1 |
2 review(s) available for pefloxacin and Primary Peritonitis
| Article | Year |
|---|---|
Flavobacterial peritonitis in patients treated by peritoneal dialysis.
Topics: Escherichia coli Infections; Flavobacterium; Gram-Negative Bacterial Infections; Humans; Kidney Failure, Chronic; Male; Middle Aged; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
CAPD peritonitis and fluoroquinolones: a review.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Ofloxacin; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1991 |
1 trial(s) available for pefloxacin and Primary Peritonitis
| Article | Year |
|---|---|
Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis.
Topics: Administration, Oral; Aged; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Middle Aged; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Treatment Failure; Vancomycin | 1993 |
15 other study(ies) available for pefloxacin and Primary Peritonitis
| Article | Year |
|---|---|
[Chemotherapeutic effectiveness of pefloxacin in experimental infections].
Topics: Acute Disease; Administration, Oral; Animals; Disease Models, Animal; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Pefloxacin; Peritonitis; Pneumonia; Sepsis | 1994 |
Investigation of the potential role of Enterococcus faecalis in the pathophysiology of experimental peritonitis.
Topics: Abscess; Amoxicillin; Animals; Anti-Bacterial Agents; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Body Weight; Disease Models, Animal; Drug Synergism; Enterococcus faecalis; Escherichia coli; Escherichia coli Infections; Gentamicins; Gram-Positive Bacterial Infections; Imipenem; Male; Microbial Sensitivity Tests; Ornidazole; Pefloxacin; Peritoneum; Peritonitis; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms | 1994 |
Oral pefloxacin in the treatment of CAPD peritonitis.
Topics: Administration, Oral; Adult; Aged; Bacterial Infections; Female; Hospitals, University; Humans; Male; Middle Aged; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1992 |
Single-dose pefloxacin pharmacokinetics and metabolism in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
Topics: Administration, Oral; Adult; Aged; Chromatography, High Pressure Liquid; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Norfloxacin; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1991 |
Plasma and dialysate levels of pefloxacin and its metabolites in CAPD patients with peritonitis.
Topics: Adult; Chromatography, High Pressure Liquid; Dialysis Solutions; Female; Follow-Up Studies; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1990 |
Oral pefloxacin mesylate in the treatment of continuous ambulatory peritoneal dialysis associated peritonitis: an open non-comparative study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Infective Agents; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Patient Compliance; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1990 |
Epileptic attacks associated with pefloxacin treatment in a patient on CAPD.
Topics: Adult; Epilepsies, Partial; Humans; Male; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1989 |
Resistance emerging after pefloxacin therapy of experimental Enterobacter cloacae peritonitis.
Topics: Animals; Bacterial Outer Membrane Proteins; DNA Topoisomerases, Type II; Drug Resistance, Microbial; Enterobacter; Enterobacteriaceae Infections; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Pefloxacin; Peritonitis; Plasmids | 1989 |
[Treatment of peritonitis in continuous ambulatory peritoneal dialysis with a combination of fosfomycin and pefloxacin].
Topics: Drug Therapy, Combination; Female; Fosfomycin; Humans; Male; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1989 |
The efficacy of pefloxacin in comparison to gentamicin in the treatment of experimentally induced peritonitis in rats.
Topics: Animals; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Bacteroides fragilis; Clostridium perfringens; Disease Models, Animal; Drug Therapy, Combination; Enterococcus faecalis; Escherichia coli; Gentamicins; Klebsiella pneumoniae; Male; Metronidazole; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Peritonitis; Proteus mirabilis; Rats; Rats, Inbred Strains | 1986 |
Peritonitis during continuous ambulatory peritoneal dialysis. Treatment with pefloxacin: first results and pharmacokinetics.
Topics: Acinetobacter Infections; Escherichia coli; Humans; Microbial Sensitivity Tests; Middle Aged; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Staphylococcal Infections; Streptococcal Infections | 1988 |
Emergence of resistance after therapy with antibiotics used alone or combined in a murine model.
Topics: Amikacin; Animals; Bacteria; Bacterial Infections; Ceftriaxone; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Escherichia coli; Female; Kanamycin; Klebsiella pneumoniae; Mice; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Serratia marcescens; Staphylococcus aureus | 1986 |
Resistance occurring after fluoroquinolone therapy of experimental Pseudomonas aeruginosa peritonitis.
Topics: Animals; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Peritonitis; Pseudomonas aeruginosa; Pseudomonas Infections | 1987 |
[Treatment of peritonitis in kidney failure patients under continuous ambulatory peritoneal dialysis by pefloxacine. Results and pharmacokinetics].
Topics: Adult; Aged; Anti-Infective Agents; Drug Tolerance; Humans; Kidney Failure, Chronic; Middle Aged; Norfloxacin; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1987 |
Management of peritonitis related to chronic ambulatory peritoneal dialysis (CAPD) using two daily intraperitoneal injections of 400 mg pefloxacin.
Topics: Bacteria; Bacterial Infections; Humans; Injections, Intraperitoneal; Microbial Sensitivity Tests; Pefloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1987 |